X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

NEW YORK CITY-Pfizer Inc. has decided to sell 685 Third Ave. in midtown to TIAA-CREF. The New York skyscraper measures 634,000 sf and is set to fetch between $180 million and $190 million. This sale by Pfizer is part of its cost cutting measures since acquiring Wyeth.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.